{"title":"Which app is right for my CVD patient?","authors":"I. Gabizon, V. Bhagirath, C. Lokker","doi":"10.31887/hm.2020.82/igabizon","DOIUrl":null,"url":null,"abstract":"Cardiovascular disease is a leading cause of mortality and morbidity, and despite efforts to identify and\ncontrol cardiovascular risk factors, significant disease burden remains. As traditional strategies to reduce cardiovascular risk are challenged by lack of resources and growing populations, new strategies are deployed, including\nthe use of smartphone applications (apps) designed to help patients manage their risk factors. For cardiovascular\ndisease, some apps specifically address one risk factor, but others include a more holistic approach to manage\nmultiple risk factors at once for primary and secondary prevention, whereas others serve as virtual cardiac rehabilitation intervention support. App stores show thousands of options in each app category, making it difficult to\nselect the appropriate ones to recommend to patients. Very few apps in the app stores are rigorously validated for\nclinical efficacy or safety, making selection even more challenging. To address this, health organizations worldwide\nhave created platforms to examine and appraise mobile health apps using standardized criteria to support clinician\nand patient app selection decisions. Now, with the rise of the COVID-19 pandemic, prolonged lockdowns have\nchallenged traditional models of care. Telemedicine for cardiovascular disease patients is advancing virtual cardiac\nrehabilitation models to replace or improve traditional care.","PeriodicalId":35477,"journal":{"name":"Heart and Metabolism","volume":"68 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31887/hm.2020.82/igabizon","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Cardiovascular disease is a leading cause of mortality and morbidity, and despite efforts to identify and
control cardiovascular risk factors, significant disease burden remains. As traditional strategies to reduce cardiovascular risk are challenged by lack of resources and growing populations, new strategies are deployed, including
the use of smartphone applications (apps) designed to help patients manage their risk factors. For cardiovascular
disease, some apps specifically address one risk factor, but others include a more holistic approach to manage
multiple risk factors at once for primary and secondary prevention, whereas others serve as virtual cardiac rehabilitation intervention support. App stores show thousands of options in each app category, making it difficult to
select the appropriate ones to recommend to patients. Very few apps in the app stores are rigorously validated for
clinical efficacy or safety, making selection even more challenging. To address this, health organizations worldwide
have created platforms to examine and appraise mobile health apps using standardized criteria to support clinician
and patient app selection decisions. Now, with the rise of the COVID-19 pandemic, prolonged lockdowns have
challenged traditional models of care. Telemedicine for cardiovascular disease patients is advancing virtual cardiac
rehabilitation models to replace or improve traditional care.